Curcumin ameliorates acute thioacetamide‐induced hepatotoxicity

Shapiro, Haim; Ashkenazi, Michal; Weizman, Noam; Shahmurov, Mark; Aeed, Hussein; Bruck, Rafael

doi:10.1111/j.1440-1746.2005.03984.x

Cited by 107 publications

(96 citation statements)

References 59 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…20) Curcumin is one of the principal curcuminoid obtained from the root of Curcuma longa, which was widely used in ancient Indian medicine for the treatment of various diseases, including liver disorders. Consistent with the traditional belief, curcumin has been shown to protect against the iron/CCl 4 -induced hepatotoxicity, 21,22) attenuate thioacetamide-induced hepatitis/cirrhosis 23,24) as well as to relieve the symptoms of cholestasis. 25) A mechanistic study of curcumin-induced proRegular Article * To whom correspondence should be addressed.…”

mentioning

confidence: 74%

Prooxidant-Induced Glutathione Antioxidant Response in Vitro and in Vivo: A Comparative Study between Schisandrin B and Curcumin

Leong

Chiu

2012

Biological & Pharmaceutical Bulletin

View full text Add to dashboard Cite

We investigated whether two naturally-occurring prooxidants, namely, schisandrin B (Sch B) and curcumin, and a synthetic prooxidant, menadione, can invariably elicit cyto/hepatoprotective responses against oxidant-induced injury. Results showed that ( )Sch B (a potent enantiomer of Sch B, 15 μM), curcumin (7.5 μM) and menadione (2 μM) induced a similar extent of reactive oxygen species production in AML12 cells. The relative potencies of cytoprotection in vitro were in a descending order of curcumin>menadione>( ) Sch B, which were parallel to the extent of stimulation in cellular reduced glutathione level. We further examined their hepatoprotection in vivo. Pretreatment with Sch B (800 mg/kg) and curcumin (737 mg/kg), but not menadione (344 mg/kg), protected against CCl 4 toxicity, with the degree of protection afforded by Sch B being much larger than that of curcumin. The attenuated hepatoprotection afforded by curcumin may be attributed to its low bioavailability in vivo. This postulation is supported by the findings that intraperitoneal injections of Sch B (400 mg/kg) and curcumin (368 mg/kg) and the long term, low dose treatment with Sch B (20 mg/kg/d 15) and curcumin (18 mg/kg/d 15) induced glutathione antioxidant response and hepatoprotection to similar extents in vivo. The inability of menadione to induce hepatoprotection may be related to its extensive intestinal metabolism and/or hepatotoxicity. Taken together, prooxidants can invariably induce the glutathione antioxidant response and confer cytoprotection in vitro. Whether or not the prooxidant can produce a similar response in vivo would depend on its bioavailability and potential toxic effect.

show abstract

mentioning

confidence: 74%

Prooxidant-Induced Glutathione Antioxidant Response in Vitro and in Vivo: A Comparative Study between Schisandrin B and Curcumin

Leong

Chiu

2012

Biological & Pharmaceutical Bulletin

View full text Add to dashboard Cite

show abstract

“…results in the hepatic damage in animals [16,17] . The mechanism behind its toxicity is thought to be associated with its toxic metabolite (s-oxide).…”

Section: Discussionmentioning

confidence: 99%

Hepatoprotective activity of Hepax–A polyherbal formulation

Devaraj¹,

Krishna²,

Viswanatha

et al. 2011

Asian Pacific Journal of Tropical Biomedicine

View full text Add to dashboard Cite

“…results in the hepatic damage in animals [14,15] . The mechanism behind its toxicity is thought to be associated with its toxic metabolite (s-oxide).…”

Section: Discussionmentioning

confidence: 99%